<DOC>
	<DOCNO>NCT02602574</DOCNO>
	<brief_summary>Post endoscopic pancreatitis ( PEP ) different initial immunologic response primary injury compare acute pancreatitis etiology ( non-PEP AP ) . The purpose study compare initial immunologic response , 24 h primary injury , patient PEP patient acute pancreatitis etiology .</brief_summary>
	<brief_title>ERCP-induced Non-ERCP Induced Acute Pancreatitis : Two Distinct Clinical Immunological Entities ?</brief_title>
	<detailed_description>PROTOCOL : All patient indication endoscopic retrograde cholangiopancreatography ( ERCP ) prepare ERCP follow protocol : instructed eat 4 6 hour procedure . Immediately procedure administrate Diclophenac Sodium 100 mg suppository . One hour procedure 10 mL blood sample urine sample take analyzed laboratory premise incorporate University Hospital Centre Rijeka follow parameter : value amylase serum urine lipase serum , liver enzyme test kidney function . 4-6 hour ERCP perform , 10 mL blood sample take analyzed laboratory premise incorporate University Hospital Centre Rijeka follow parameter : value amylase serum urine lipase serum , liver enzyme test kidney function . 24 hour procedure patient take 30 ml heparinized peripheral venous blood urine sample . 10 mL examine Department Laboratory Medicine , Clinical Hospital Centre follow parameter : value amylase serum urine lipase serum , liver enzyme test kidney function . Urine sample collect procedure use evaluate amylase level . Other 20 mL blood sample send Department Physiology Immunology , School Medicine immunologic analysis perform . All patient underwent ERCP divide two group . First group ( PEP group ) make patient developed acute pancreatitis follow ERCP . Upon clinical laboratory confirmation acute pancreatitis accord European Society Gastrointestinal Endoscopy ( ESGE ) guideline post-ERCP pancreatitis , monitor hospitalization evaluation severity disease . Severity disease assess accord Cotton criterion severity post-ERCP pancreatitis . Group patient underwent ERCP n't develop acute pancreatitis within 24 hour procedure , accord ESGE guideline use control group ( non-PEP group ) . All patient acute pancreatitis accord Atlanta criterion admit Emergency Department take 30 ml heparinized peripheral venous blood urine sample upon 24 hour clinical symptom start ( upper abdominal pain often radiate back ) . 10 mL collect blood sample examine Department Laboratory Medicine , Clinical Hospital Centre follow parameter : value amylase serum urine lipase serum , liver enzyme test kidney function . Other 20 mL blood sample send Department Physiology Immunology , School Medicine immunologic analysis perform . This group patient monitor hospitalization evaluation severity disease . Severity disease assess accord Atlanta criterion . METHODS AND MATERIALS Laboratory parameter For patient include study blood urine analysis perform Department Laboratory Medicine , Clinical Hospital Centre Rijeka . Basic hematology test include : total blood count - count total number red blood cell , white blood cell platelets present blood , value hemoglobin hematocrit . Biochemical analysis blood serum include : value amylase lipase serum , sodium , potassium , glucose , liver enzymes ( aspartate aminotransferase ( AST ) , alanine aminotransferase ( ALT ) , Gama-glutamyl transferase ( GGT ) , alkaline phosphatase ( ALP ) ) direct indirect bilirubin , kidney function ( serum urea creatinine , estimate glomerular filtration ( eGFR ) ) , C-reactive protein acid-base status arterial blood . Immunological method For patient include study immunologic analysis blood sample ( 24 hour procedure onset symptom ) perform Department Physiology Immunology , School Medicine Rijeka , Croatia . Isolation peripheral blood mononuclear cell Twenty milliliter peripheral blood acquire Vacutainer ( Becton Dickinson , Franklin Lakes , NY ) , overlay onto Lymphoprep ( Nycomed Pharma AS , Oslo , Norway ) centrifuge ( 20 min 600 g ) . After centrifugation , cell interface collect washed twice Roswell Park Memorial Institute ( RPMI ) 1640 medium ( Auckland , NZ ) use immediately experimental procedure . The viability cell &gt; 95 % assessed propidium iodide 0.5 mg/ml/106 cell ( Sigma-Aldrich Chemie ) flow cytometer ( FACSCalibur , Becton Dickinson , San Jose , USA ) Detection cell surface Peripheral blood mononuclear cell ( PBMC ) stain 30 min 40 degree Celsius different combination Phycoerythrin ( PE ) - Cyanine ( Cy ) anti-cluster differentiation ( CD ) 3 monoclonal antibody ( mouse Antibody ( mAb ) , Immunoglobulin G 1 ( IgG1 ) ) , PE-conjugated anti-cluster differentiation ( CD ) 56 mAb ( mouse B159 , IgG1 ) fluorescein isothiocyanate ( FITC ) -conjugated anti-natural-killer group 2 , member D ( NKG2D ) mAb ( 5C6 ) . FITC- , PE- PE-Cy conjugate mouse isotype match antibody use set negative control class antibody use . Stained cell sample analyze flow cytometry use FACSCalibur flow cytometer ( Becton Dickinson &amp; Co , San Jose , USA ) . Detection cytokine Interleukin ( IL ) -1 beta ( β ) heat shock protein ( HSP ) 70 , 27 . For quantitative determination human IL-1 β concentration plasma , Human IL-1 ELISA ( Enzyme-Linked Immunosorbent Assay ) Kit use . For quantitative determination heat shock protein ( HSP ) 70 27 plasma , HSP 70 High sensitivity ELISA Kit HSP 27 ELISA kit use . Detection pentraxin 3 ( PTX 3 ) procalcitonin For quantitative determination human pentraxin 3 ( PTX ) procalcitonin concentration plasma specific ELISA Kit use .</detailed_description>
	<mesh_term>Pancreatitis</mesh_term>
	<criteria>patient underwent ERCP irrespectively diagnosis patient diagnose acute pancreatitis accord Atlanta criterion admit Emergency Department within 24 hour onset symptom . unwillingness inability consent study anticipate inability follow protocol , previous ERCP , acute cholecystitis and/or cholangitis active recent ( within 4 week ) gastrointestinal hemorrhage exist acute pancreatitis ( lipase peak ) within 72 hour prior ERCP intrauterine pregnancy , breast feeding mother patient chronic inflammatory disease ( e.g . IBD ) systemic inflammatory autoimmune disorder ( e.g . systemic lupus erythematosus , ) acute inflammatory disease ( e.g . pneumonia , pyelonephritis sepsis cause ) patient immunomodulatory immunosuppressive therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Cholangiopancreatography , Endoscopic Retrograde</keyword>
	<keyword>Pancreatitis</keyword>
	<keyword>Heat-Shock Proteins</keyword>
	<keyword>Pentraxin 3 protein</keyword>
	<keyword>C-Reactive Protein</keyword>
	<keyword>procalcitonin</keyword>
	<keyword>Interleukin-1 beta</keyword>
	<keyword>Leukocytes , Mononuclear</keyword>
	<keyword>Killer Cells , Natural</keyword>
	<keyword>natural-killer group 2 , member D receptor</keyword>
</DOC>